Depression risk lurks in the genes

LONDON: Researchers say it’s now beyond doubt that depression has a biological basis as well as being the result of circumstance, as the world’s largest study into the genetics of the condition identifies almost 700 genes associated with risk.

An individual’s propensity to develop major depression – which affects one in five people throughout their lifetime – will be able to be quantified in future through gene screening, with the scientists finding that individuals who had variations in several genes associated with depression were likelier to be affected by the condition.

The Genetics of Depression Study led by scientists at the University of Edinburgh and King’s College London, which included Australian researchers from QIMR Berghofer, the University of Queensland and the Brain and Mind Centre in Sydney, studied genetic samples from 680,000 people worldwide as well as samples from four million people who had never had depression.

Fifty of the newly identified gene variants came from results from genes analysed that were supplied by 16,000 Australians who donated samples as part of the Australian Genetics of Depression Study.

The researchers found 697 genes were associated with depression, an increase of about 300 from those previously identified.

“It’s almost double what we knew previously and they implicated some very specific kind of cell types within the brain and biological pathways that we didn’t really know about before which offer potential targets for new treatments,” QIMR Berghofer researcher Brittany Mitchell said.

Dr Mitchell said it was the combined effects of combinations of depression-associated gene variants that appeared to raise people’s risk. Researchers have already identified based on common combined gene variant patterns that two existing drugs used to treat chronic pain and the sleep disorder narcolepsy may be able to be used to treat depression.

Scientists around the world will now use the results of the Genetics of Depression Study to begin analysing how common combined variants may be targeted with personalised therapies.

The results also will be used to examine why some people respond to antidepressant medications and others don’t, based on genetic variants they carry.

The increased understanding of the biological basis of depression and its various genetic drivers also could help unlock the mystery of the so-called serotonin hypothesis.

Antidepressants have been long marketed by drug companies to work by increasing the level of serotonin in the brain. Although this theory is now scientifically debunked, scientists do not understand the exact mechanism of action of antidepressant medications, and why they have high efficacy for some people and do not work for others.

Dr Mitchell said the effect of gene variants in causing depression had not yet been thoroughly studied. Scientists’ theory was that a person’s genetics influenced the cells and neurons involved in brain signalling. If the brain’s signalling processes were altered, that could result in the commonly reported symptom in depressed patients of a slowing down of the brain and a feeling of detachment from the world.

Genes also could have an effect on brain hormones such as serotonin and dopamine. Slow metabolisers of serotonin may have higher levels of that hormone in their brains, for instance, and therefore be less susceptible to depression.

However, genetics is not determinative. Experiences such as trauma have a large bearing on whether someone who may have a genetic propensity will go on to experience depression. Adverse experiences can influence a person’s epigenetics. Epigenetics is akin to an extra layer of function that is superimposed on your genes. That is, your lifestyle and experiences change the expression of your genes.

“Depression is a very complicated disorder, and though we’re making really big strides and progress in what we know about its underpinnings and what causes it, I think we do still have some way to go,” Dr Mitchell said.

“But this is a really important step in that direction.”